Clinical Challenges
ASH: DLBCL
American Society of Hematology
More in ASH: DLBCL
Regimen is approved for frontline treatment, but when it represents the best choice is less clear
Dec 18, 2023
Regimen is approved for frontline treatment, but when it represents the best choice is less clear